CMV pp65 peptide GPISGHVLK (HLA-A*1101)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
CMV pp65 peptide GPISGHVLK (HLA-A*1101)

CMV pp65 peptide GPISGHVLK (HLA-A*1101) is a single peptide for stimulation of T cells. The peptide from human cytomegalovirus (CMV) phosphoprotein (pp65) is synthesized as it is presented by the MHC class I HLA-A*1101 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: GPISGHVLK
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*1101

Podobne produkty

MHC I-Strep HLA-B*0801; EBV BZLF1 (RAKFKQLL)

MHC I-Strep HLA-B*0801; EBV BZLF1 (RAKFKQLL)

IBA Lifescience
Więcej
CD22 antigen peptide QLQWLLEGV (HLA-A*0201)

CD22 antigen peptide QLQWLLEGV (HLA-A*0201)

IBA Lifescience
Więcej
MHC I-Strep HLA-A*0201; Survivin (ELTLGEFLKL)

MHC I-Strep HLA-A*0201; Survivin (ELTLGEFLKL)

IBA Lifescience
Więcej